Understanding cell death in Parkinson's disease
- PMID: 9749577
- DOI: 10.1002/ana.410440712
Understanding cell death in Parkinson's disease
Abstract
Current concepts of the cause of Parkinson's disease (PD) suggest a role for both genetic and environmental influences. Common to a variety of potential causes of nigral cell degeneration in PD is the involvement of oxidative stress. Postmortem analysis shows increased levels of iron, decreased complex I activity, and a decrease in reduced glutathione (GSH) levels. The decrease in GSH levels may be a particularly important component of the cascade of events leading to cell death because it occurs in the presymptomatic stage of PD and may directly induce nigral cell degeneration or render neurons susceptible to the actions of toxins. There is evidence suggesting that oxidative stress might originate in glial cells rather than in neurons, and alterations in glial function may be an important contributor to the pathologic process that occurs in PD. Oxidative damage occurs in the brain in PD, as shown by increased lipid peroxidation and DNA damage in the substantia nigra. Increased protein oxidation is also apparent, but this occurs in many areas of the brain and raises the specter of a more widespread pathologic process occurring in PD to which the substantia nigra is particularly vulnerable. The inability of the substantia nigra to handle damaged or mutant (eg, alpha-synuclein) proteins may lead to their aggregation and deposition and to the formation of Lewy bodies. Indeed, Lewy bodies stain for both alpha-synuclein and nitrated proteins. Current evidence enables us to hypothesize that a failure to process structurally modified proteins in regions of the brain exhibiting oxidative stress is a cause of both familial and sporadic PD.
Similar articles
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
Oxidative mechanisms in nigral cell death in Parkinson's disease.Mov Disord. 1998;13 Suppl 1:24-34. Mov Disord. 1998. PMID: 9613715 Review.
-
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Epub 2010 Sep 23. J Neural Transm (Vienna). 2011. PMID: 20862500 Review.
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
Cited by
-
Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway.Mar Drugs. 2013 Mar 28;11(4):1019-34. doi: 10.3390/md11041019. Mar Drugs. 2013. PMID: 23538867 Free PMC article.
-
Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons.J Neurosci. 2003 Sep 17;23(24):8586-95. doi: 10.1523/JNEUROSCI.23-24-08586.2003. J Neurosci. 2003. PMID: 13679428 Free PMC article.
-
A portrait of the Bcl-2 protein family: life, death, and the whole picture.J Clin Immunol. 1999 Nov;19(6):365-77. doi: 10.1023/a:1020598632068. J Clin Immunol. 1999. PMID: 10634210 Review.
-
The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion.Neurotox Res. 2002 Feb;4(1):77-81. doi: 10.1080/10298420290007655. Neurotox Res. 2002. PMID: 12826496
-
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.J Psychiatry Neurosci. 2002 Jan;27(1):12-27. J Psychiatry Neurosci. 2002. PMID: 11836973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical